Erbi Biosystems, Inc.

United States - Stoneham, Massachusetts

• 04/01/2022
• Unknown
• $4,000,000

Erbi Biosystems is revolutionizing cell therapy and bioprocessing process development with the Breez, a fully automated 2 mL TruePerfusion™ bioreactor. Scarce and expensive raw materials no longer restrict generation of process development data enabling improved CMC. A single 2mL volume cassette can deliver up to 400M (CHO and T-cells), sufficient for most development needs and a number of CAR-T clinical dose regimes.

The platform offers a 90% footprint reduction using disposable, functionally closed single-use cassettes with proprietary microfluidic technology processes capable of performing activation, transduction, intensified growth, and diafiltration steps. It offers closed-loop control of pH, total cell density (OD), dissolved oxygen, and CO2 measurements. The integrated online sensors and intuitive software deliver sophisticated feeding strategies, increased cell concentration, low shear, bubble-free mixing with high kLa resulting in performance far exceeding the static and benchtop reactors typically used today.

#CellTherapy4All #CellTherapyforAll

Related People

Michael ChiuFounder

United States - Somerville, Massachusetts

Entrepreneurial general manager focused on developing and commercializing early-stage technologies. Broad range of experience from startups to S&P500 companies.

Founder, CEO of VC-backed startup with successful exit.

GM of a global technology business unit with >$60M in revenues.

Led development of multiple new products from concept to successful market introduction. Responsible for marketing, engineering, supply-chain, applications and support.

Experience with corporate operations, finance, governance and M&A.

Specialties: Leading entrepreneurial teams
New product development and marketing
Strategy and systems architecture of complex technologies and businesses

LinkedIn https://www.linkedin.com/in/michaelachiu/